Rozporządzenie Ministra Zdrowia z dnia 24 lutego 2023 r. zmieniające rozporządzenie w sprawie programu pilotażowego leczenia gruźlicy wielolekoopornej w warunkach ambulatoryjnych
This preamble identifies the regulation as an amending regulation about a pilot program for outpatient treatment of multidrug-resistant tuberculosis and states that the Minister of Health administers the health government department.
AI-assisted research synopsis — verify against the official legal text below.
- Jurisdiction
- Poland
- Instrument
- Regulation
- Citation
- Dz.U. 2023 poz. 372
- Version
- Undated source snapshot
- Language
- pl
- Updated
- Official source
- View official record ↗
Publicly available, excluded from search-engine indexing
This page remains available for direct access and API use, but this release emits
noindex,follow for the following reason:
- The record does not meet this release's canonical indexing criteria.
(market-indexing-disabled)
Statute overview
About this statute
This preamble identifies the regulation as an amending regulation about a pilot program for outpatient treatment of multidrug-resistant tuberculosis and states that the Minister of Health administers the health government department. The provided excerpt contains only numbering markers and no readable substantive rule. This provision amends an existing health regulation, changing one visit frequency from monthly to once every three months and adding a final medical consultation fee of 150 zł for MDR-TB treatment. It also updates the annex list of facilities and states the regulation takes effect the day after publication.
Ask AI about this statute
Rozporządzenie Ministra Zdrowia z dnia 24 lutego 2023 r. zmieniające rozporządzenie w sprawie programu pilotażowego leczenia gruźlicy wielolekoopornej w warunkach ambulatoryjnych
Sign in to ask AI about this statute
Sign in to start authenticated, citation-grounded statute research.
Sign in